PO-20 A HYDROGEN SULFIDE PRODRUG AUGMENTS ANGIOGENESIS IN A SWINE MODEL OF CRITICAL LIMB ISCHEMIA VIA A NITRIC OXIDE DEPENDENT MECHANISM
Introduction: Despite advances in revascularization, treatments for critical limb ischemia (CLI) have been largely unsuccessful. Hydrogen sulfide (H2S) and nitric oxide (NO), are endogenous gasotransmitters which exert potent vasodilatory and proangiogenic effects. Recent experimental evidence sugge...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2016-11-01
|
| Series: | Artery Research |
| Online Access: | https://www.atlantis-press.com/article/125930516/view |
| _version_ | 1811252582614564864 |
|---|---|
| author | Amanda M. Rushing Amy L. Scarborough Sarah F. Boisvert Erminia Donnarumma Rishi Trivedi David J. Polhemus David J. Lefer Traci T. Goodchild |
| author_facet | Amanda M. Rushing Amy L. Scarborough Sarah F. Boisvert Erminia Donnarumma Rishi Trivedi David J. Polhemus David J. Lefer Traci T. Goodchild |
| author_sort | Amanda M. Rushing |
| collection | DOAJ |
| description | Introduction: Despite advances in revascularization, treatments for critical limb ischemia (CLI) have been largely unsuccessful. Hydrogen sulfide (H2S) and nitric oxide (NO), are endogenous gasotransmitters which exert potent vasodilatory and proangiogenic effects. Recent experimental evidence suggest that the proangiogenic effects of H2S are medicated in part through the NO pathway. We sought to determine whether a novel H2S prodrug, SG-1002 (Sulfagenix, Inc. Cleveland OH), increases NO production and promotes peripheral revascularization.
Methods: CLI was generated in Yucatan miniswine (n=17) via carotid cutdown and placement of an Amplatzer vascular plug deployed within a Viabahn stent positioned proximally in the external iliac artery. At day 7 post-CLI pigs, received daily placebo or SG-1002 (1600 mg PO). Cuff-pressures were measured weekly by ankle/brachial index (ABI). Plasma H2S, H2S metabolite sulfane sulfur (SS), and NO metabolite, nitrite (NO2) were measured. At day 42 post-CLI, digital subtraction angiography (DSA) was performed and opacified vessels quantitated.
Results: ABI was reduced to 0 following CLI induction. ABI improved in both groups but continued to demonstrate persistent ischemia with values below 0.25 at day 42 and showed no difference between groups. Circulating H2S levels were similar between groups. SS levels were increased from baseline to day 42 in SG-1002 treated pigs (p < 0.001) but remained unchanged in placebo treated animals. At day 42, SG-1002 treatment increase circulating NO2 levels (p < 0.05) compared to placebo. There was an increase in NO2 levels from baseline to day 42 in SG-1002 treated pigs (p < 0.05). DSA revealed an increase of CLI limb vessel number in SG-1002 treated pigs compared to placebo (p < 0.05).
Conclusions: Treatment with the H2S prodrug, SG-1002, results in increased metabolites of H2S and NO signaling. H2S treatment increased vascular density in the setting of severe CLI in a clinical relevant swine model. |
| first_indexed | 2024-04-12T16:36:55Z |
| format | Article |
| id | doaj.art-b01b62aab70747d78c5cf18557207d8c |
| institution | Directory Open Access Journal |
| issn | 1876-4401 |
| language | English |
| last_indexed | 2024-04-12T16:36:55Z |
| publishDate | 2016-11-01 |
| publisher | BMC |
| record_format | Article |
| series | Artery Research |
| spelling | doaj.art-b01b62aab70747d78c5cf18557207d8c2022-12-22T03:24:57ZengBMCArtery Research1876-44012016-11-011610.1016/j.artres.2016.08.026PO-20 A HYDROGEN SULFIDE PRODRUG AUGMENTS ANGIOGENESIS IN A SWINE MODEL OF CRITICAL LIMB ISCHEMIA VIA A NITRIC OXIDE DEPENDENT MECHANISMAmanda M. RushingAmy L. ScarboroughSarah F. BoisvertErminia DonnarummaRishi TrivediDavid J. PolhemusDavid J. LeferTraci T. GoodchildIntroduction: Despite advances in revascularization, treatments for critical limb ischemia (CLI) have been largely unsuccessful. Hydrogen sulfide (H2S) and nitric oxide (NO), are endogenous gasotransmitters which exert potent vasodilatory and proangiogenic effects. Recent experimental evidence suggest that the proangiogenic effects of H2S are medicated in part through the NO pathway. We sought to determine whether a novel H2S prodrug, SG-1002 (Sulfagenix, Inc. Cleveland OH), increases NO production and promotes peripheral revascularization. Methods: CLI was generated in Yucatan miniswine (n=17) via carotid cutdown and placement of an Amplatzer vascular plug deployed within a Viabahn stent positioned proximally in the external iliac artery. At day 7 post-CLI pigs, received daily placebo or SG-1002 (1600 mg PO). Cuff-pressures were measured weekly by ankle/brachial index (ABI). Plasma H2S, H2S metabolite sulfane sulfur (SS), and NO metabolite, nitrite (NO2) were measured. At day 42 post-CLI, digital subtraction angiography (DSA) was performed and opacified vessels quantitated. Results: ABI was reduced to 0 following CLI induction. ABI improved in both groups but continued to demonstrate persistent ischemia with values below 0.25 at day 42 and showed no difference between groups. Circulating H2S levels were similar between groups. SS levels were increased from baseline to day 42 in SG-1002 treated pigs (p < 0.001) but remained unchanged in placebo treated animals. At day 42, SG-1002 treatment increase circulating NO2 levels (p < 0.05) compared to placebo. There was an increase in NO2 levels from baseline to day 42 in SG-1002 treated pigs (p < 0.05). DSA revealed an increase of CLI limb vessel number in SG-1002 treated pigs compared to placebo (p < 0.05). Conclusions: Treatment with the H2S prodrug, SG-1002, results in increased metabolites of H2S and NO signaling. H2S treatment increased vascular density in the setting of severe CLI in a clinical relevant swine model.https://www.atlantis-press.com/article/125930516/view |
| spellingShingle | Amanda M. Rushing Amy L. Scarborough Sarah F. Boisvert Erminia Donnarumma Rishi Trivedi David J. Polhemus David J. Lefer Traci T. Goodchild PO-20 A HYDROGEN SULFIDE PRODRUG AUGMENTS ANGIOGENESIS IN A SWINE MODEL OF CRITICAL LIMB ISCHEMIA VIA A NITRIC OXIDE DEPENDENT MECHANISM Artery Research |
| title | PO-20 A HYDROGEN SULFIDE PRODRUG AUGMENTS ANGIOGENESIS IN A SWINE MODEL OF CRITICAL LIMB ISCHEMIA VIA A NITRIC OXIDE DEPENDENT MECHANISM |
| title_full | PO-20 A HYDROGEN SULFIDE PRODRUG AUGMENTS ANGIOGENESIS IN A SWINE MODEL OF CRITICAL LIMB ISCHEMIA VIA A NITRIC OXIDE DEPENDENT MECHANISM |
| title_fullStr | PO-20 A HYDROGEN SULFIDE PRODRUG AUGMENTS ANGIOGENESIS IN A SWINE MODEL OF CRITICAL LIMB ISCHEMIA VIA A NITRIC OXIDE DEPENDENT MECHANISM |
| title_full_unstemmed | PO-20 A HYDROGEN SULFIDE PRODRUG AUGMENTS ANGIOGENESIS IN A SWINE MODEL OF CRITICAL LIMB ISCHEMIA VIA A NITRIC OXIDE DEPENDENT MECHANISM |
| title_short | PO-20 A HYDROGEN SULFIDE PRODRUG AUGMENTS ANGIOGENESIS IN A SWINE MODEL OF CRITICAL LIMB ISCHEMIA VIA A NITRIC OXIDE DEPENDENT MECHANISM |
| title_sort | po 20 a hydrogen sulfide prodrug augments angiogenesis in a swine model of critical limb ischemia via a nitric oxide dependent mechanism |
| url | https://www.atlantis-press.com/article/125930516/view |
| work_keys_str_mv | AT amandamrushing po20ahydrogensulfideprodrugaugmentsangiogenesisinaswinemodelofcriticallimbischemiaviaanitricoxidedependentmechanism AT amylscarborough po20ahydrogensulfideprodrugaugmentsangiogenesisinaswinemodelofcriticallimbischemiaviaanitricoxidedependentmechanism AT sarahfboisvert po20ahydrogensulfideprodrugaugmentsangiogenesisinaswinemodelofcriticallimbischemiaviaanitricoxidedependentmechanism AT erminiadonnarumma po20ahydrogensulfideprodrugaugmentsangiogenesisinaswinemodelofcriticallimbischemiaviaanitricoxidedependentmechanism AT rishitrivedi po20ahydrogensulfideprodrugaugmentsangiogenesisinaswinemodelofcriticallimbischemiaviaanitricoxidedependentmechanism AT davidjpolhemus po20ahydrogensulfideprodrugaugmentsangiogenesisinaswinemodelofcriticallimbischemiaviaanitricoxidedependentmechanism AT davidjlefer po20ahydrogensulfideprodrugaugmentsangiogenesisinaswinemodelofcriticallimbischemiaviaanitricoxidedependentmechanism AT tracitgoodchild po20ahydrogensulfideprodrugaugmentsangiogenesisinaswinemodelofcriticallimbischemiaviaanitricoxidedependentmechanism |